2010
DOI: 10.1177/1076029610375815
|View full text |Cite
|
Sign up to set email alerts
|

Polymorphisms and Mutations in vWF and ADAMTS13 Genes and Their Correlation With Plasma Levels of FVIII and vWF in Patients With Deep Venous Thrombosis

Abstract: Despite the tempting assumption that genetic factors that change ADAMTS13 activity might modulate the risk of DVT by altering vWF and FVIII levels, the polymorphisms analyzed in this study did not correlate with DVT risk among patients investigated.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
18
0
2

Year Published

2015
2015
2019
2019

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 21 publications
(21 citation statements)
references
References 25 publications
1
18
0
2
Order By: Relevance
“…No association was found for this SNP, while variant c.2699C>T showed increased risk. The variant c.1852C>G was also studied in relation to deep venous thrombosis (DVT), with no association observed [34]. The rarer variants c.3178C>T and c.4143_4144dupA have not previously been investigated in association studies.…”
Section: Discussionmentioning
confidence: 99%
“…No association was found for this SNP, while variant c.2699C>T showed increased risk. The variant c.1852C>G was also studied in relation to deep venous thrombosis (DVT), with no association observed [34]. The rarer variants c.3178C>T and c.4143_4144dupA have not previously been investigated in association studies.…”
Section: Discussionmentioning
confidence: 99%
“…Cancer patients have been shown to have higher VWF levels and lower ADAMTS‐13 levels than the general population, often also in a stage‐dependent intensity …”
Section: Introductionmentioning
confidence: 99%
“…In a recent study VWF and ADAMTS‐13 were shown to be associated with occurrence of VTE in cancer patients, with ADAMTS‐13 exhibiting predictive potential in risk scores . Patients with VTE or history of VTE have been repeatedly shown to have higher mean levels of VWF, however, patients with underlying malignancy have always been excluded. Data on ADAMTS‐13 and its association with VTE, on the other hand, is ambiguous.…”
Section: Introductionmentioning
confidence: 99%
“…In humans both immobilization that decreases blood flow and tissue damage from a traumatic event increase the risk of DVT by 10- to 20-fold (Heit et al 1999, 2000; Esmon 2009). An increase in the level of procoagulant proteins (e.g., clotting factors, fibrinogen, von Willebrand factor-vWF) or a reduced level of anticoagulant proteins (e.g., antithrombin, protein C) increases the risk for thrombosis and embolism (Bertina 2003; Kuipers et al 2009; Bittar et al 2010; Flinterman et al 2010; Ribeiro et al 2012). Platelets, monocytes, and neutrophils also contribute to DVT through the formation of DNA neutrophil extracellular traps (NETS) in baboon and mouse models (Chauhan et al 2007; Fuchs et al 2010; Brill et al 2011).…”
Section: Introductionmentioning
confidence: 99%